- Home
- PLUG vs XENE Comparison
PLUG vs XENE Comparison
Compare PLUG & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- XENE
- Stock Information
- Founded
- PLUG 1997
- XENE 1996
- Country
- PLUG United States
- XENE Canada
- Employees
- PLUG N/A
- XENE N/A
- Industry
- PLUG Industrial Machinery/Components
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- PLUG Energy
- XENE Health Care
- Exchange
- PLUG Nasdaq
- XENE Nasdaq
- Market Cap
- PLUG 2.9B
- XENE 2.9B
- IPO Year
- PLUG 1999
- XENE 2014
- Fundamental
- Price
- PLUG $3.85
- XENE $41.90
- Analyst Decision
- PLUG Hold
- XENE Strong Buy
- Analyst Count
- PLUG 16
- XENE 11
- Target Price
- PLUG $2.29
- XENE $52.73
- AVG Volume (30 Days)
- PLUG 194.8M
- XENE 775.1K
- Earning Date
- PLUG 11-11-2025
- XENE 11-11-2025
- Dividend Yield
- PLUG N/A
- XENE N/A
- EPS Growth
- PLUG N/A
- XENE N/A
- EPS
- PLUG N/A
- XENE N/A
- Revenue
- PLUG $672,844,000.00
- XENE $7,500,000.00
- Revenue This Year
- PLUG $15.17
- XENE N/A
- Revenue Next Year
- PLUG $24.45
- XENE $207.88
- P/E Ratio
- PLUG N/A
- XENE N/A
- Revenue Growth
- PLUG N/A
- XENE N/A
- 52 Week Low
- PLUG $0.69
- XENE $26.74
- 52 Week High
- PLUG $4.58
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- PLUG 65.51
- XENE 66.02
- Support Level
- PLUG $3.58
- XENE $39.35
- Resistance Level
- PLUG $4.58
- XENE $41.66
- Average True Range (ATR)
- PLUG 0.46
- XENE 1.54
- MACD
- PLUG 0.06
- XENE 0.17
- Stochastic Oscillator
- PLUG 69.46
- XENE 95.28
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.